Instrument overview

BYSIBeyondSpring

StockNasdaqUnited StatesHealth careEU retail investors: available

−6.9% today · −67.6% over a year

No score: too little data.

No dividend.

BeyondSpring (BYSI) belongs to the Health care sector and is listed on Nasdaq; country: United States. Its market value is about €23.2M. Over the past 12 months the price changed by −67.6%, with an annualised volatility of 111% and a largest fall of 82%. Hard red flags in our rules-based screen: Financial distress.

Not scored: not enough data for a fair comparison.

Red flags and notes

  • Serious warning. Altman Z in the distress zone and negative free cash flow. More in the glossary → Altman Z in the distress zone and negative free cash flow.
  • Caution. Negative free cash flow in at least two of the last three years. More in the glossary → Negative free cash flow in at least two of the last three years.
  • Caution. Median daily trading below €100,000: wider spreads and harder exits. More in the glossary → Median daily trading below €100,000: wider spreads and harder exits.
  • Caution. Book equity is below zero. More in the glossary → Book equity is below zero.
  • Below $1 Price below one US dollar: not ranked against peers.
  • Sources disagree Dividend or fundamental sources disagree beyond tolerance.

Our sources disagree or are incomplete for this instrument.

Price chart

Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.

Key metrics

Valuation

Free-cash-flow yield
−64.4%
Market cap (EUR)
€23.2M

Dividends

Dividend yield
0.00%
Years without a lower dividend
0

Returns and risk

1 day
−6.9%
1 month
−19.6%
1 year
−67.6%
Volatility, 1 yr
111.0%
Max drawdown, 1 yr
−81.7%
Beta
0.30

Ratios from SEC filings and end-of-day prices; returns are price changes without dividends.

Similar companies

Same sector and region, closest in market value.

HRTXHeron Therapeutics Inc—/100.0%−74.8%
SKINSkinHealth Systems2/100.0%−64.8%
ATRAAtara Biotherapeutics Inc—/100.0%−26.0%
VXRTVaxart Inc—/100.0%12.1%
FRNMFreenome Inc.—/100.0%−2.4%
LENZLENZ Therapeutics, Inc.1/100.0%−86.0%
BDTXBlack Diamond Therapeutics Inc—/100.0%−57.1%
AVXLAnavex Life Sciences Corp.—/100.0%−84.8%

News and filings

What the marks mean
  • FactA filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.
  • Media reportA headline from a named media outlet. We link to it and do not check it.
  • RumourUnconfirmed: the headline itself hedges (“reportedly”, “sources say”, “in talks”), names no publisher, or comes from a news aggregator or an automated republisher.

Source: Filings: U.S. SEC EDGAR. The tone is scored automatically from the headline and can be wrong.

Score changes in the last 12 months

Every published rating and change, logged when it was published (EU Market Abuse Regulation).

Show the log: 1 entry
DateEventBalancedGrowth · IncomeWarningsPrice at publication
First rating —/10 — · — Available with Invest Pro

Ratings are rules-based descriptions, valid until the next scoring run (about 06:20 and 21:50 UTC) and the same for every visitor.